Related references
Note: Only part of the references are listed.The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
Michael Pollak
CLINICAL CANCER RESEARCH (2012)
Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
Irene Asmane et al.
EUROPEAN JOURNAL OF CANCER (2012)
Beware the creeping cracks of bias
Daniel Sarewitz
NATURE (2012)
Raise standards for preclinical cancer research
C. Glenn Begley et al.
NATURE (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Heterogeneity and Tumor History
Darryl Shibata
SCIENCE (2012)
Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma
Simon Ekman et al.
ACTA ONCOLOGICA (2011)
Dynamics of cancer cell subpopulations in primary and metastatic colorectal tumors
Teodora Evgenieva Goranova et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
Tamara Aleksic et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
被撤回的出版物: Molecular Analysis of Non-Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition (Retracted article. See vol. 20, pg. 3358, 2014)
Antonio Gualberto et al.
CLINICAL CANCER RESEARCH (2010)
Silencing of the Insulin Receptor Isoform A Favors Formation of Type 1 Insulin-Like Growth Factor Receptor (IGF-IR) Homodimers and Enhances Ligand-Induced IGF-IR Activation and Viability of Human Colon Carcinoma Cells
G. V. Brierley et al.
ENDOCRINOLOGY (2010)
Lentivirus-mediated shRNA targeting insulin-like growth factor-1 receptor (IGF-1R) enhances chemosensitivity of osteosarcoma cells in vitro and in vivo
Yin-He Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab(CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos et al.
LANCET ONCOLOGY (2010)
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival
D. Sachdev et al.
ONCOGENE (2010)
Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
Danielle B. Ulanet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA
Demian Cazalla et al.
SCIENCE (2010)
SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor
Bita Sehat et al.
SCIENCE SIGNALING (2010)
The insulin receptor substrate-1: A biomarker for cancer?
Renato Baserga
EXPERIMENTAL CELL RESEARCH (2009)
Mechanism of Growth Inhibition by MicroRNA 145: The Role of the IGF-I Receptor Signaling Pathway
Gaspare La Rocca et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Tumours with PI3K activation are resistant to dietary restriction
Nada Y. Kalaany et al.
NATURE (2009)
Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
A. Gualberto et al.
ONCOGENE (2009)
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
Ahmad M. Khalil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors
Elizabeth Buck et al.
CANCER RESEARCH (2008)
Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells
Bin Shi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of insulin receptor isoforms and hybrid Insulin/IGF-I receptors in human cancer
Antonino Belfiore
CURRENT PHARMACEUTICAL DESIGN (2007)
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells
S. A. Byron et al.
BRITISH JOURNAL OF CANCER (2006)
The insulin-like growth factor-1 receptor as a target for cancer therapy
R Baserga
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Why most published research findings are false
JPA Ioannidis
PLOS MEDICINE (2005)
Role of insulin-like growth factor 1 receptor signalling in cancer
O Larsson et al.
BRITISH JOURNAL OF CANCER (2005)
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
SY Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth
A Girnita et al.
CANCER RESEARCH (2004)
The igf-1 receptor in cancer biology
R Baserga et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
Nuclear localization of EGF receptor and its potential new role as a transcription factor
SY Lin et al.
NATURE CELL BIOLOGY (2001)
The contradictions of the insulin-like growth factor 1 receptor
R Baserga
ONCOGENE (2000)
The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity
M Aoki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)